Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
Johanna Chapin-Bardales, Julianne Gee, Tanya R. Myers
Abstract
Kimberly G. Blumenthal, MD, MSc; Lacey B. Robinson, MD, MPH; Carlos A. Camargo Jr, MD, DrPH; Erica S. Shenoy, MD, PhD; Aleena Banerji, MD; Adam B. Landman, MD; Paige Wickner, MD, MPH
Topics & Concepts
MedicineReactogenicityReceiptCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyFamily medicineInternal medicineImmunologyImmunogenicityWorld Wide WebImmune systemInfectious disease (medical specialty)DiseaseComputer scienceOutbreakSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies